Cost-of-illness studies of depression. A systematic review

Journal of Affective Disorders

Volumn 98, Issue 1-2, 2007, Pages 29-43

  Luppa, Melanie ^a   Heinrich, Sven ^a   Angermeyer, Matthias C ^a   König, Hans Helmut ^a   Riedel Heller, Steffi G ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Cost of illness; Depression; Economic burden; Systematic review

Indexed keywords

ANXIETY DISORDER; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; COST UTILITY ANALYSIS; DEPRESSION; DYSTHYMIA; HEALTH CARE COST; HUMAN; MAJOR DEPRESSION; MORBIDITY; MORTALITY; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW;

COST OF ILLNESS; DEPRESSION; DEPRESSIVE DISORDER; GERMANY; HUMANS; INCIDENCE;

EID: 33845970612     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2006.07.017     Document Type: Review

References (50)

1. Andlin-Sobocki P., and Wittchen H.U. Cost of affective disorders in Europe. Eur. J. Neurol. 12 (2005) 34-38
2. Australian Bureau of Statistics (ABS). Population by Age and Sex of South Australia (3235,4) (2000)
3. Behrens C., and Henke K. Cost of illness studies: no aid to decision making: Reply to Shiell et al. (Health Policy, 8 (1987) 317-323). Health Policy 2 (1988) 137-141
4. Berto P., D'Ilario D., Ruffo P., Di Virgilio R., and Rizzo F. Depression: cost-of-illness studies in the international literature, a review. J. Mental Health Policy Econ. 3 (2000) 3-10
5. Chisholm D., Knapp M.R., Knudsen H.C., Amaddeo F., Gaite L., and van Wijngaarden B. Client Socio-Demographic and Service Receipt Inventory-European Version: development of an instrument for international research. EPSILON Study 5. Br. J. Psychiatr., Suppl. (2000) 28-33
6. Chisholm D., Amir M., Fleck M.P.A., Herrman H., Lomachenkov A., Lucas R., and Patrick D. Longitudinal Investigation of Depression Outcomes (The LIDO Study) in primary care in six countries: comparative assessment of local health systems and resource utilization. Int. J. Methods Psychiatr. Res. 10 (2001) 59-71
7. Chisholm D., Diehr P., Knapp M., Patrick D., Treglia M., Simon G., and LIDO Group. Depression status, medical comorbidity and resource costs. Evidence from an international study of major depression in primary care (LIDO). Br. J. Psychiatry 183 (2003) 121-131
8. Druss B.G., Rosenheck R.A., and Sledge W.H. Health and disability costs of depressive illness an a Major U.S. Corporation. Am. J. Psychiatr. 157 (2000) 1274-1278
9. Friemel S., Bernert S., Angermeyer M.C., and König H.H. The direct costs of depressive disorders in Germany. Psychiatr. Prax. 32 (2005) 113-121 (German)
10. Federal Statistical Office (FSO). Statistical Yearbook 2005 for the Federal Republic of Germany (2005), Wiesbaden 234-256 German
11. Goff V.V. Depression: a decade of progress, more to do. NHPF Issue Brief 786 (2002) 1-14
12. Greenberg P.E., Stiglin L.E., Finkelstein S.N., and Berndt E.R. The economic burden of depression in 1990. J. Clin. Psychiatry 54 (1993) 405-418
13. Greenberg P.E., Kessler R.C., Birnbaum H.G., Leong S.A., Lowe S.W., Berglund P.A., and Corey-Lisle P.K. The economic burden of depression in the United States: how did it change between 1990 and 2000?. J. Clin. Psychiatry 64 (2003) 1465-1475
14. Hawthorne G., Cheok F., Goldney R., and Fisher L. The excess cost of depression in South Australia: a population-based study. Aust. N. Z. J. Psychiatry 37 (2003) 362-373
15. Henriksson F., and Jönsson B. Hälsekonomiska aspekter pa depressionsjukdomen. In: SBU (Ed). Behandling av depresssionssjukdomar. En sysematisk litteraturöversikt (2004), SBU, Stockholm, Sweden 443-476
16. Hu T.W. The economic burden of depression and reimbursement policy in the Asia Pacific region. Australas. Psychiatry 12 (2004) 11-15
17. International Monetary Fund (IMF). World Economic Outlook (2005)
18. Jönsson B., and Bebbington P.E. Economic studies of the treatment of depressive illness. In: Jönsson B., and Rosenbaum J. (Eds). Health Economics of Depression (1993), Wiley, Chichester 35-48
19. Jönsson B., and Bebbington P.E. What price depression? The cost of depression and the cost-effectiveness of pharmacological treatment. Br. J. Psychiatry 164 (1994) 665-673
20. Katon W.J., Lin E., Russo J., and Unützer J. Increased medical costs of a population-based sample of depressed elderly patients. Arch. Gen. Psychiatry 60 (2003) 897-903
21. Kind P., and Sörensen J. The costs of depression. Int. Clin. Psychopharmacol. 7 (1993) 191-195
22. Koopmanschap M.A. Cost-of-illness studies. Useful for health policy?. PharmacoEcon. 14 (1998) 143-148
23. Löthgren M. Economic evidence in affective disorders: a review. Eur. J. Health Econ. 5 (2004) 12-20
24. Luber M.P., Hollenberg J.P., Williams-Russo P., DiDomenico T.N., Meyers B.S., Alexopoulos G.S., and Charlson M.E. Diagnosis, treatment, comorbidity, and resource utilization of depressed patients in a general medical practice. Int. J. Psychiatry Med. 30 (2000) 1-13
25. Luber M.P., Meyers B.S., Williams-Russo P.G., Hollenberg J.P., DiDomenico T.N., Charlson M.E., and Alexopoulos G.S. Depression and service utilization in elderly primary care patients. Am. J. Geriatr. Psychiatry 9 (2001) 169-176
26. In: Murray C.J.L., and Lopez A.D. (Eds). Global Comparative Assessments in the Health Sector: Disease Burden, Expenditure and Intervention Packages (1994), World Health Organization, Geneva
27. Murray C.J.L., and Lopez A.D. Alternative visions of the future: projecting mortality and disability, 1990-2020. In: Murray C.J.L., and Lopez A.D. (Eds). The Global Burden of Disease. A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries and Risk Factors in 1990 and Projected to 2020. Publication from the Harvard School of Public Health, on Behalf of the World Health Organization and the World Bank (1996), Harvard University Press, Cambridge, MA 361-395
28. Norinder A., Nordling S., and Haggstrom L. Treatment of depression and cost efficiency. The cost of a tablet is a poor indicator seen from a socioeconomic perspective. Lakartidningen 97 (2000) 1693-1700 (Swedish)
29. Office for National Statistics (ONS) in the United Kingdom. Population Trends vol. 90 (1997) 51
30. Olfson M., Marcus S.C., Druss B., Elinson L., Tanielian T., and Pincus H.A.. National trends in the outpatient treatment of depression. JAMA 2 (2002) 203-209
31. Organisation for Economic Co-operation and Development (OECD) Health Data. Statistics and Indicators for 30 Countries (2005)
32. Regier D.A., Myers J.K., Kramer M., Robins L.N., Blazer D.G., Hough R.L., Eaton W.W., and Locke B.Z. The NIMH Epidemiologic Catchment Area program. Historical context, major objectives, and study population characteristics. Arch. Gen. Psychiatry 41 (1984) 934-941
33. Rice D.P. Cost-of-illness studies: fact or fiction?. Lancet 344 (1994) 1519-1520
34. Rice D.P., and Miller L.S. The economic burden of affective disorders. Br. J. Psychiatry 166 (1995) 34-42
35. Rupp A. The economic consequences of not treating depression. Br. J. Psychiatry 27 (1995) 29-33 (Review)
36. Salize H.J., Stamm K., Schubert M., Bergmann F., Harter M., Berger M., Gaebel W., and Schneider F. Cost of care for depressive disorders in primary and specialized care in Germany. Psychiatr. Prax. 31 (2004) 147-156 (German)
37. Sartorius N., Üstün T.B., Costa e Silva J.A., Goldberg D., Lecrubier Y., Ormel J., Von Korff M., and Wittchen H.U. An international study of psychological problems in primary care. Preliminary report from the World Health Organization Collaborative Project on 'Psychological Problems in General Health Care'. Arch. Gen. Psychiatry 50 (1993) 819-824
38. Sheehan D.V. Depression: underdiagnosed, undertreated, underappreciated. Manag. Care 6 (2004) 6-8 (suppl.)
39. Shiell A., Gerard K., and Donaldson C. Cost of illness studies: An aid to decision-making?. Health Policy 3 (1987) 317-323
40. Simon G., Ormel J., Von Korff M., and Barlow W. Health care costs associated with depressive and anxiety disorders in primary care. Am. J. Psychiatry 152 (1995) 352-357
41. Simon G.E., Von Korff M., and Barlow W. Health care costs of primary care patients with recognized depression. Arch. Gen. Psychiatry 52 (1995) 850-856
42. Stoudemire A., Frank R., Hedemark N., Kamlet M., and Blazer D. The economic burden of depression. Gen. Hosp. Psych. 8 (1986) 387-394
43. Tarricone R. Metodologia di indagine e primi risultati ul costo sociale della depressione maggiore in Italia. Mecosan 6 (1997) 57-68
44. Thomas C.M., and Morris S. Cost of depression among adults in England in 2000. Br. J. Psychiatry 183 (2003) 514-519
45. Trivedi D., Lawrence L., Blake S.G., Rappaport H.M., and Feldhaus J. A study of the economic burden of depression. J. Pharm. Fin. Econ. Policy 13 (2004) 51-66
46. Unützer J., Patrick D.L., Simon G., Grembowski D., Walker E., Rutter C., and Katon W. Depressive symptoms and the cost of health services in HMO patients aged 65 years and older. A 4-year prospective study. JAMA 277 (1997) 1618-1623
47. West R. Depression (1992), Office of Health Economics, London 28-31
48. World Bank. World Development Indicators (2005)
49. Yeh L.L., Lee Y.C., Yang M.C., Lau S.K., and Hwu H.G. The economic cost of the severely mentally ill patients. Chin. J. Ment. Health (1999) 1-15 (Chinese)
50. Zuvekas S.H. Trends in mental health services use and spending, 1987-1996. Health Aff. (Millwood) 2 (2001) 214-224